Adam Friedman et al., Nanoparticle-Encapsulated Doxorubicin Demonstrates Superior Tumor Cell Kill in Triple Negative Breast Cancer Subtypes Intrinsically Resistant to Doxorubicin

Precis. Nanomed. 2018 Oct;1(3):173-182

POTENTIAL CLINICAL SIGNFICANCE